BIOMARKERS EUROPE 2024
BIOMAKERS EUROPE 2024
Gain insights into Biomarker approaches & accelerate timelines in drug development for oncology and immuno-related therapies
Overview
Formed of the 3rd Annual Biomarkers Europe and 2nd Annual Precision Oncology Europe Congresses, Biomarkers Europe 2024 is focused on driving the advancement of biomarkers within the fields of oncology and immunotherapy.
The co-located events provide a specialized platform to explore the most innovative technologies and approaches for biomarker validation & Identification, biomarker analysis, applications in precision oncology & patient treatment in clinical trials.
With over 50 presentations, these two-day congresses provide multiple opportunities for engaging scientific insights, valuable networking, and interactive panel & workshop discussions.
Over 500 leading industry experts and clinicians will engage on biomarker end points, personalised patient treatment and companion diagnostics development including early detection technologies & liquid biopsies.
3rd Annual Biomarkers Europe Congress
Addressing challenges in biomarker analysis to accelerate timelines in drug development including the role of safety and efficacy biomarkers . Discover novel approaches into optimising biomarker analysis through effective assay development, as well as utilising the latest multiplexed tools impacting biomarker research and validation.
Acquire knowledge about how biomarker approaches are utilized in drug discovery and translational sciences for oncology and immuno-related therapies.
Explore how companies accelerate timelines and reduce risk in drug development. Presentations consider the latest applications of Biomarker Analysis – Multiplex Technology Application & Translational Research in oncology & Immunological disorders
Gain insights into emerging bioanalysis approaches, assay development, and what can be translated in the clinic
2nd Annual Precision Oncology Europe Congress
Bringing together experts In Oncology And Cancer Care, Clinical Research, and Drug Development To Explore application in diagnosis, stratification & prognosis in oncology, and advancing personalized treatment to improve patient outcomes.
Showcasing the latest technologies and clinical studies in multi-cancer early detection and minimal residual disease testing
Learn about molecular characterization of tumour for targeted therapy selection
Explore biomarker and companion diagnostics discovery, and development
Gain insights from genomics-enabled clinical trials for tailored cancer drug development
Explore Spatial Biology Europe 2024: Unlocking Future Insights in Spatial Biology Research
Join leaders, experts and researchers at the 3rd Annual Spatial Biology Europe Congress, connecting global academic & research organisations as well as pharma representatives for high-level discussions on the latest innovations in spatial research & technologies. Forward looking visionary leaders will discuss the current state of the industry, market trends and future growth areas aiding the application of spatial technologies in the clinic.
Take a deep dive into image analysis, AI-powered imaging, and utilising digital pathology for spatial biology. Key opinion leaders will be providing insights into computational image analysis, multiplexed digital pathology, and the utilisation of AI & machine learning within spatial transcriptomic studies
Discuss the latest innovations in spatial bioinformatics and data analytics. Presentations will delve into the use of spatial data in biology, modelling cell-cell communications, and computational algorithms for spatial analysis. A focused workshop will investigate how to overcome the challenges of spatial data integration
Gain comprehensive insights into novel application areas for spatial biology. This event will cover the applications of spatial data across a variety of therapeutic areas including neuroimmunology, oncology, cardiology and more. Discussions will also involve strategies for making spatially targeted therapeutics more precise
Hear from leading innovators utilizing spatial biology in pharma. See how leading pharmaceutical companies are beginning to integrate spatial biology into R&D to accelerate timelines and move towards the clinic
What to Expect
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programmed, attendees can engage in a variety of event features and make the most of participation in a range of experiences.
Engaging Thought Leadership
Over 50 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts.
Global Technological Showcase
An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
Networking Emphasis
Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
Innovative Poster Displays
Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions
Meet Our Expert Speakers
Benjamin Weber
Vice President Translational Research,
Novo Nordisk
Brian Lockhart
Global Head of Companion Diagnostics,
Servier
Ed Schuuring
Clinical Scientist in Molecular Pathology,
umcg
Gunther Jansen
Head of Multimodal Data & Analytics,
Novartis
Joanna Janus
Research Programme Manager (Early Detection and Prevention),
Cancer Research UK
Olga Nissan
CEO,
Protica Bio
Related Contents
- How To Overcome Challenges in Image Analysis for Spatial Biology w/ Lorenz Rognoni, Ultivue
- A role for HALO® in characterizing cell heterogeneity across organ systems: from the liver to the brain
- BIOMARKERS US 2024
- DIGITAL PATHOLOGY 101
- Are image analysis algorithms for digital pathology compliant with regulatory requirements?
Comments are closed.